Phaseline

Targets › HIV

HIV: drug programs, companies and trials

1 program from 1 company in 3 trials: 3 Phase 1; Infectious disease.

Open in Phaseline: the race on HIV, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
U.S. Army Medical Research and Development CommandAd26.Mos4.HIV
Recombinant adenovirus 26-vectored HIV-1 vaccine expressing mosaic envelope antigens
HIVPhase 1Human Immunodeficiency Virus–

Conditions

Human Immunodeficiency Virus (3)

Modalities

protein or peptide (1)

Companies

U.S. Army Medical Research and Development Command (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.